Proteomic Analysis of Colorectal Cancer Using Free-Flow Electrophoresis
Author Information
Author(s): Robert L. Moritz, Anita R. Skandarajah, Hong Ji, Richard J. Simpson
Primary Institution: Ludwig Institute for Cancer Research (Melbourne Branch)
Hypothesis
The study investigates the effectiveness of free-flow electrophoresis as a prefractionation tool for proteomic analysis in colorectal cancer.
Conclusion
The 2D liquid-based FFE-IEF/RP-HPLC method shows promise for analyzing complex proteins and low-Mr compounds, potentially aiding in the identification of biomarkers for early colorectal cancer detection.
Supporting Evidence
- Colorectal cancer is a leading cause of cancer death in the Western world.
- Early detection significantly improves survival rates for colorectal cancer patients.
- Current genomic methods have not reliably produced candidate biomarkers for colorectal cancer.
Takeaway
This study looks at a new way to separate proteins in colorectal cancer, which could help doctors find signs of the disease earlier.
Methodology
The study describes a proteomics separation tool using continuous free-flow electrophoresis followed by rapid reversed-phase HPLC.
Limitations
The study does not provide specific limitations but acknowledges challenges in detecting low-abundance proteins.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website